Dr. Vivian T. Laquer, MD

Dr. Laquer practices at Tien Q Nguyen Inc in Fountain Valley, California.

Dr. Laquer's NPI, 1164656229, was assigned on May 5, 2009. Dr. Laquer graduated from Vagelos College of Physicians and Surgeons in 2009. Dr. Laquer's California license number on file is A113693.

Dr. Laquer's primary practice is Tien Q Nguyen Inc, at 17271 Brookhurst St, Fountain Valley, CA 92708 in Orange County. The practice phone is (714) 531-2966.

Dr. Laquer's primary practice is Tien Q Nguyen Inc in Fountain Valley, California. Dr. Laquer is also affiliated with UCI Health - Orange. The medical group on file is First OC Dermatology. Dmand AI also links Dr. Laquer to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Laquer practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Laquer's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Laquer is board certified in dermatology by the American Board of Dermatology. Dr. Laquer has a license on file in California.

Dmand AI lists benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, itchy rashes, psoriasis, scalp rash, shingles and skin cyst among the conditions Dr. Laquer treats.

CMS data shows 624 Medicare services from Dr. Laquer across 3 procedure codes in 2024, for 70 Medicare patients. Medicare paid $81,050 for them. Every service was in an office.

CMS counts 70 Medicare patients who saw Dr. Laquer in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 66% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Laquer's median patient age at 63, with 57% women.

In 2024, Dr. Laquer wrote 58 Medicare Part D claims for 20 patients. 76% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $193 in total drug cost. In 2023, CMS named 70 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Laquer for performance year 2024, reported through an alternative payment model (APM). Dr. Laquer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 612 procedures of removal of skin lesions by Dr. Laquer, more than 88% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 26 papers to Dr. Laquer, published from 2008 to 2024. 2021 was the busiest year, with 5. The most frequent topics are Double-Blind Method, Dermatitis, Atopic and Antibodies, Monoclonal, Humanized. Dr. Laquer has published most often in J Am Acad Dermatol. Dr. Laquer's most frequent co-authors are John Caleb Browning, MD, Sunil S. Dhawan, MD and Kristen Marie Kelly, MD.

Dmand AI links Dr. Laquer to 10 clinical trials. Conditions studied include Dermatitis, Atopic, Eczema and Psoriasis. Eli Lilly and Company sponsors the most, 10. Open Payments lists research payments to Dr. Laquer that name 12 trials.

CMS Open Payments shows 1,111 general payments to Dr. Laquer from 42 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. Eli Lilly and Company paid the most, $29,751. It also lists 42 research payments totaling $301,763 from 2018 to 2024, naming 12 clinical trials.

Dr. Laquer graduated from Vagelos College of Physicians and Surgeons in 2009.

Dr. Laquer is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.